Please login to the form below

Not currently logged in
Email:
Password:

Akorn Pharma

This page shows the latest Akorn Pharma news and features for those working in and with pharma, biotech and healthcare.

Fresenius says Akorn investigation could affect takeover

Fresenius says Akorn investigation could affect takeover

Fresenius Kabi says its $4.3bn deal to acquire US generic drugmaker Akorn Pharma could be scuppered by an FDA probe of the generic drug manufacturer. ... period of 2016, with the declines all coming from the prescription pharma business.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics